scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JACI.2010.01.056 |
P698 | PubMed publication ID | 20392487 |
P50 | author | Hirohisa Saito | Q39961579 |
Peter Bradding | Q41855963 | ||
Glenn Cruse | Q55079496 | ||
P2093 | author name string | Hironori Sagara | |
Chisei Ra | |||
Yoshimichi Okayama | |||
Naoki Kajiwara | |||
Kazumitsu Ohmori | |||
Tomomi Sasaki | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mast cell | Q191989 |
P304 | page(s) | 1137-1145.e6 | |
P577 | publication date | 2010-04-14 | |
P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
P1476 | title | Activation of human mast cells through the platelet-activating factor receptor | |
P478 | volume | 125 |
Q37403748 | An essential role for platelet-activating factor in activating mast cell migration following ultraviolet irradiation |
Q27011610 | Anaphylactic reaction to platelet transfusion as the initial symptom of an undiagnosed systemic mastocytosis: a case report and review of the literature |
Q55374006 | Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers. |
Q34192100 | Anaphylaxis: mechanisms and management |
Q42292311 | CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells |
Q33427338 | Early recognition is the key to success: pulseless electrical activity (PEA) as a manifestation of heparin-induced anaphylactoid reaction |
Q37734315 | Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells |
Q30438074 | Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design. |
Q90614167 | FcεRI-HDAC3-MCP1 Signaling Axis Promotes Passive Anaphylaxis Mediated by Cellular Interactions |
Q30458593 | Food-induced anaphylaxis. |
Q90357108 | Function of secreted phospholipase A2 group-X in asthma and allergic disease |
Q33831022 | Genomic responses during acute human anaphylaxis are characterized by upregulation of innate inflammatory gene networks |
Q36505809 | IgE-Mediated Anaphylaxis to Foods, Venom, and Drugs: Influence of Serum Angiotensin Converting Enzyme Levels and Genotype |
Q28276574 | Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets |
Q89937684 | Mas-related G protein coupled receptor-X2: A potential new target for modulating mast cell-mediated allergic and inflammatory diseases |
Q24296488 | Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization |
Q64899299 | Mast Cells and Their Progenitors in Allergic Asthma. |
Q28510556 | Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis |
Q27687421 | Mast cell modulation of the vascular and lymphatic endothelium |
Q35014406 | Mast cell stabilization alleviates acute lung injury after orthotopic autologous liver transplantation in rats by downregulating inflammation |
Q83029950 | Mast cells and inflammation |
Q38633155 | Mast cells in asthma--state of the art. |
Q42030753 | Mechanisms, Cofactors, and Augmenting Factors Involved in Anaphylaxis |
Q37956534 | Mediators released during human anaphylaxis |
Q47800446 | Neuro-immune interactions in allergic diseases: novel targets for therapeutics |
Q60301536 | Neutrophil oxidative burst as a diagnostic indicator of IgG-mediated anaphylaxis |
Q93016483 | Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications |
Q44098562 | Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation |
Q90613314 | Platelets trigger perivascular mast cell degranulation to cause inflammatory responses and tissue injury |
Q36539857 | Potential effector and immunoregulatory functions of mast cells in mucosal immunity |
Q34986991 | Recognition and management of food-induced anaphylaxis |
Q35377560 | RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock. |
Q28079028 | Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases |
Q37821491 | Rupatadine for the treatment of allergic rhinitis and urticaria |
Q36240870 | Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function |
Q47810222 | The pathophysiology of anaphylaxis |
Q28544768 | Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin |
Q37156655 | Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer |
Q64944377 | Unique Lipid Signatures of Extracellular Vesicles from the Airways of Asthmatics. |
Q38285821 | Update on rupatadine in the management of allergic disorders |
Q47151536 | Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1. |
Q37798030 | What's new in asthma pathophysiology and immunopathology? |
Q38375846 | n-3 Polyunsaturated fatty acids and mast cell activation |
Q36951709 | β-Defensins activate human mast cells via Mas-related gene X2. |